Yang et al. found that TR4 may function through altering the OCT4 and IL1Rα to modulate the PCa progression [13], and TR4 could also alter the PCa cells’ radio-sensitivity and might become a prognostic indicator for PCa patients receiving radiotherapy [10]. This evidence concerns the gene NR2C2 and posterior cortical atrophy.